United States: Medicare Proposes Sweeping Changes To Physician Payments

Miranda A. Franco is a senior public affairs advisor in our Washington D.C. office.


  • The Centers for Medicare & Medicaid Services (CMS) released a proposed rule to implement major Medicare physician payment reform provisions included in the Medicare Access and CHIP Reauthorization Act (MACRA). 
  • The act would implement reforms to tie physician payment updates to quality, value and participation in alternative payment and delivery models.
  • Healthcare industry professionals need to understand Medicare's evolving payment structures so they can position their organizations for success in the new value-based world.

The Centers for Medicare & Medicaid Services (CMS) released on April 27, 2016, the highly anticipated proposed rule to implement major Medicare physician payment reform provisions included in the Medicare Access and CHIP Reauthorization Act (MACRA). 

The MACRA repealed the Medicare sustainable growth rate (SGR) formula and directed the Secretary of Health and Human Services to implement reforms to tie physician payment updates to quality, value and participation in alternative payment and delivery models. The law fundamentally changed how Medicare pays clinicians who participate in the program and established two tracks for Medicare reimbursement.

More specifically, the MACRA mandates the development of the Merit-based Incentive Payment System (MIPS) to replace existing physician quality programs, including the Physician Quality Reporting System (PQRS), the Value-based Payment Modifier (VM) and the Electronic Health Records (EHR) Incentive Program (Meaningful Use) beginning Jan. 1, 2019.

The MACRA also mandates incentives for providers to participate in alternative payment models (APMs) that focus on coordinating care, improving quality and reducing costs. The Secretary of Health and Human Services must establish criteria for physician-focused APMs, including models for specialist physicians, by Nov. 1, 2016.

The regulation is complex with many interwoven pieces, all ostensibly to be accomplished within an aggressive timetable. However, it is important to note that a lot could change between now and the release of final rule. The CMS asks for stakeholders to share thoughts on how to improve the current parameters. The next few months present an important opportunity to participate in the comment period and share thoughts with the agency.

The proposal was published in the Federal Register on May 9, 2016. Comments are due at 5 p.m. EST on June 27, 2016.

Highlights of the proposed rule include:

  • establishing a new approach to quality reporting that seeks to streamline and simplify the disparate PQRS, VM and Meaningful Use programs into a single MIPS, a new program for certain Medicare-enrolled clinicians
  • setting 2017 as the first performance measurement year for the new MIPS
  • detailing criteria for qualification as an APM participant, including eligibility for future incentive payments
  • detailing criteria for use by the Physician-Focused Payment Model Technical Advisory Committee (PTAC)

Key provisions of the proposed rule include:


Performance Period
The performance period is a full calendar year – Jan. 1 through Dec. 31. Calendar Year (CY) 2017 is proposed as the first performance period on which the CMS plans to base the CY 2019 payment adjustment.

Eligible clinicians (as opposed to eligible professionals (EPs) per the MACRA) include physicians, physician assistants (PAs), nurse practitioners (NPs), clinical nurse specialists (CNS), certified registered nurse anesthetists (CRNAs) and groups that include such physicians.

The CMS has authority to expand the definition of MIPS-eligible clinicians to include additional clinicians through rulemaking in future years and may do so for other clinicians who are currently reporting through the PQRS.

MIPS-Eligible Clinician Identifier
MIPS-eligible clinicians have the flexibility to submit information individually or via a group. The CMS will allow the use of both Taxpayer Identification Number (TIN) and National Provider Identifier (NPI) identifiers in MIPS. Clinicians can choose to report at either the TIN or the NPI level, as long as the organization or individual is consistent in how the information is submitted across all performance categories.

MIPS contains numerous proposals exempting certain subsets of providers from MIPS participation, including 1) Medicare newly enrolled (first year) clinicians, 2) clinicians below the low-volume threshold and 3)certain participants in Advanced APMs.

MIPS does not apply to hospitals or facilities.

Performance Categories and Scoring
As outlined in the MACRA, the proposal would consolidate three currently disparate Medicare quality programs into MIPS: 1) the Physician Quality Reporting System (PQRS), 2) the Value-based Payment Modifier (VM) and 3) the Electronic Health Records (EHR) Incentive Program (Meaningful Use). The CMS proposes that eligible clinicians receive composite scores relative to their performances in each of the four categories. Quality measures for these core domains will be selected annually, with the data regarding clinician performance on the measures made available via the Physician Compare website.

  • Quality (50 percent of the total score in year one): This category would replace the PQRS and the quality component of the VM. Eligible clinicians would report six measures versus the nine required under the PQRS. This category gives clinicians a variety of reporting options to accommodate differences in specialty and practice with an emphasis on outcome measurement.
  • Advancing Care Information (25 percent of the total score in year one): This category was formerly Meaningful Use. Clinicians would choose to report customizable measures that reflect how they use technology in their day-to-day practices with a particular emphasis on interoperability and information exchange. Unlike the existing reporting program, this category would not require all-or-nothing EHR measurement or redundant quality reporting. Further, the CMS proposes to reduce the number of quality reporting measures from 18 to 11 and remove the requirement to report on two measures that cross-cut two or more National Quality Forum (NQF) domains – participants will no longer be required to report on Clinical Decision Support (CDS) and the Computerized Provider Order Entry (CPOE) measures. However, under an alternate proposal, the CMS offered to include them.
  • Clinical Practice Improvement Activities (CPIA) (15 percent of the total score in year one): This category would reward clinical practice improvements, such as activities focused on care coordination, beneficiary engagement and patient safety. Clinicians may select activities that match their practices' goals from a list of more than 90 options. In addition, clinicians would receive credit in this category for participating in APMs and Patient-Centered Medical Homes (PCMHs).
  • Cost (10 percent of total score in year one): This category's score would be based on Medicare claims, meaning no reporting requirements for clinicians. This category would use 40 episode-specific measures to account for differences among specialties.

Composite Performance Score (CPS) Under MIPS
The four performance category scores would be aggregated into a MIPS CPS. The MIPS CPS would be compared against a MIPS performance threshold. The CPS would be used to determine whether a MIPS-eligible clinician receives an upward payment adjustment, no payment adjustment or a downward payment adjustment as appropriate.

MIPS Adjustments
The law requires MIPS to be budget neutral. Therefore, clinicians' MIPS scores would be used to compute a positive, negative or neutral adjustment to their Medicare Part B payments. In the first year, depending on the variation of MIPS scores, adjustments are calculated so that negative adjustments can be no more than 4 percent and positive adjustments are generally up to 4 percent with additional bonuses for the highest performers.

Per the law, both positive and negative adjustments would increase over time. Additionally, in the first five payment years of the program, the law allows for $500 million in an additional performance bonus that is exempt from budget neutrality for exceptional performance. This exceptional performance bonus will provide high performers with a gradually increasing adjustment based on their MIPS scores that can be no higher than an additional 10 percent. As specified under the statute, negative adjustments would increase over time and positive adjustments would correspond. The maximum negative adjustments for each year are 4 percent in 2019, 5 percent in 2020, 7 percent in 2021 and 9 percent in 2022.

Advanced APMs

APM Incentive Payments
From 2019 through 2024, Qualifying APM Professionals (QPs) would receive a lump sum payment equal to 5 percent of the estimated aggregate payment amounts for Part B services. Beginning in 2026, payment rates under the Physician Fee Schedule (PFS) will be updated by the 0.75 percent qualifying APM conversion factor. Eligible clinicians who are QPs for a year are also excluded from MIPS for that year. This QP determination is made for one calendar year at a time. To qualify for incentive payments, clinicians would have to receive enough of their payments or see enough of their patients through Advanced APMs.

Advanced APM Requirements
This rule proposes two types of Advanced APMs: Advanced APMs and Other Payer Advanced APMs. To be an Advanced APM, an APM must 1) require participants to use certified EHR technology, 2) provide payment for covered professional services based on quality measures comparable to those used in the quality performance category of MIPS and 3) be either a medical home model or bear more than a nominal amount of risk for monetary loss. The requirements for an Other Payer Advanced APM are virtually the same, but these APMs are intended to be a commercial or Medicaid APMs. In addition, the CMS is proposing to notify the public of which APMs will be Advanced APMs prior to each QP performance period.

Advanced APM Qualifications
Under the agency's criteria for payment models to be eligible for the APM track, the Bundled Payments for Care Improvement (BPCI) initiative, the Comprehensive Care for Joint Replacement (CJR) model and Track 1 of the Medicare Shared Savings Program (MSSP) will not qualify. Notably, the rule does not address whether the CMS will allow Track 1 accountable care organizations (ACOs) to switch MSSP tracks mid-participation agreement to join an Advanced APM.

The proposed rule includes a list of models that would qualify as Advanced APMs as they all require downside risk. These include:

  • Comprehensive End-Stage Renal Disease (ESRD) Care Model (large dialysis organization arrangement)
  • Track 2 of the Medicare Shared Savings Program
  • Track 3 of the Medicare Shared Savings Program
  • Oncology Care Model (OCM) two-sided risk arrangement (available in 2018)
  • Next Generation ACO Model
  • Comprehensive Primary Care Plus (CPC+)

Under the statute, medical home models that have been expanded under the Center for Medicare & Medicaid Innovation authority qualify as Advanced APMs regardless of whether they meet the financial risk criteria. While medical home models have not yet been expanded, the proposed rule lays out criteria for medical home models to ensure that primary care physicians have opportunities to participate in Advanced APMs.

Physician-Focused Payment Models (PFPMs)
The CMS proposes three criteria for PFPMs that outline requirements for 1) paying for high-value care, 2) promoting care delivery improvements and 3) improving the availability of information for decision-making, including though health information technology (IT). 

Takeaways and Conclusions

The proposed rule is further evidence of the desire of the CMS to accelerate the transition from volume to value through targeted incentives. This is the strongest attempt by the CMS to get to risk-based APMs. The MACRA incentivizes physicians to move into Advanced or Other Payer Advanced APMs through several different mechanisms, including a guaranteed 5 percent bonus for six years and a permanent annual 0.75 percent fee schedule bump.

The initial performance benchmark year is set to begin Jan. 1, 2017. As a result, clinicians will be forced to make practice model selection decisions over the next 12 months. Further, APMs and MIPS will increasingly influence care patterns in favor of treatments that improve downstream clinical, financial and patient-reported outcomes. Going forward, those in the healthcare industry should pay close attention to these incentives and to Medicare's evolving payment structures so they can position their organizations for success in the new value-based world.   

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions